PapersPMID:36903391
Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents.
What moved
1 findingHow to read these marks →- Inhibits NLRP3
very limited
“Compared with the findings in 5-FU group, the expression level of NLRP3 in the spleen significantly decreased and that of IL-10 significantly increased in the Ber-CD and Con-Ber groups (p < 0.05).”
- Study
- animal · not in humans
- Duration
- 3 days
- Dose studied
- native berberine (Con-Ber) 5 mg/kg/day, intraperitoneal, days 3-5
- Population
- C57BL/6 mice with 5-fluorouracil-induced intestinal mucositis, spleen
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- C57BL/6 mice, male, 5-fluorouracil (5-FU)-induced intestinal mucositis model
- Participants
- 32
- Comparator
- an active treatment
- Duration
- 5 days
- Endpoints measured
- 11
berberine